—
C+
C+ The full Closelook — membership. Open the C+ overview

Edwards Lifesciences Corp (EW) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Edwards Lifesciences Corp

EW in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Edwards Lifesciences makes devices to treat heart valve disease, sold in the United States, Europe, Japan and elsewhere. Its main products are transcatheter heart valves under the Sapien range, used to replace the aortic valve without open surgery, plus the Pascal and Evoque devices, which repair or replace mitral and tricuspid valves. It also sells surgical valves under the Inspiris and Konect Resilia names for open-heart procedures, reaching hospitals through its own sales force and independent distributors. The company is based in Irvine, California, and has been listed since 2000.
Where it sits in the stack
Edwards Lifesciences carries no seat in Rubin, the diary's AI build-out index; it sits in our Healthcare sleeve, under Medical Devices, alongside other cardiovascular device makers.
Who it is priced against
The diary's peer group is not set for Edwards; the market most often compares it with Medtronic in heart valve therapies.
Why Closelook tracks it
It holds a seat in the S&P 500 but carries no Rubin index seat and no Closelook score; the diary has not yet quoted it.
What the diary watches
The diary watches for regulatory approvals or new indications that widen the use of its transcatheter valve platforms.

Edwards Lifesciences Corp (EW) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for EW, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Medical Devices · United States · 8 names with week and year-to-date

Peer group

Medical Devices · United States

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against EW on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Edwards Lifesciences Corp (EW)?

Edwards Lifesciences Corp trades as EW on the US exchange (United States) in the Closelook research universe, as of the registry build of 2026-09-18.

Is EW in a Closelook index?

Not currently — Edwards Lifesciences Corp is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

Where does EW trade against its moving averages?

Pullback inside an uptrend stack: Trades -0.4% vs the 50-day and +3.8% vs the 200-day average, 8.3% below the 52-week high and +22.1% off the 52-week low. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Edwards Lifesciences Corp do?

Edwards Lifesciences makes devices to treat heart valve disease, sold in the United States, Europe, Japan and elsewhere. Its main products are transcatheter heart valves under the Sapien range, used to replace the aortic valve without open surgery, plus the Pascal and Evoque devices, which repair or replace mitral and tricuspid valves. It also sells surgical valves under the Inspiris and Konect Resilia names for open-heart procedures, reaching hospitals through its own sales force and independent distributors. The diary's peer group is not set for Edwards; the market most often compares it with Medtronic in heart valve therapies.

Where does Edwards Lifesciences Corp sit in the AI build-out?

Edwards Lifesciences carries no seat in Rubin, the diary's AI build-out index; it sits in our Healthcare sleeve, under Medical Devices, alongside other cardiovascular device makers. It holds a seat in the S&P 500 but carries no Rubin index seat and no Closelook score; the diary has not yet quoted it.

What does this page show?

A live price chart with SMA overlays and drawing tools for EW, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Medical Devices. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.